HHV-8-negative multicentric Castleman disease presenting as a crescentic immune complexes membranoproliferative glomerulonephritis.
Adrenal Cortex Hormones
/ therapeutic use
Antigen-Antibody Complex
Castleman Disease
/ complications
Cyclophosphamide
/ therapeutic use
Diagnosis, Differential
Drug Therapy, Combination
Glomerulonephritis, Membranoproliferative
/ drug therapy
Herpesvirus 8, Human
Humans
Immunologic Factors
/ therapeutic use
Immunosuppressive Agents
/ therapeutic use
Male
Middle Aged
Rituximab
/ therapeutic use
acute renal failure
proteinurea
Journal
BMJ case reports
ISSN: 1757-790X
Titre abrégé: BMJ Case Rep
Pays: England
ID NLM: 101526291
Informations de publication
Date de publication:
06 Jan 2020
06 Jan 2020
Historique:
entrez:
9
1
2020
pubmed:
9
1
2020
medline:
15
8
2020
Statut:
epublish
Résumé
Multicentric Castleman disease is a rare polyclonal lymphoproliferative disorder mainly associated with two renal manifestations: thrombotic microangiopathy and amyloidosis. Nevertheless, we report here a case of human herpes virus-8 negative multicentric Castleman disease with membranous proliferative glomerulonephritis and extracapillary proliferation. A patient was successfully treated with corticosteroids, anti-CD20 and cyclophosphamide therapy.
Identifiants
pubmed: 31911409
pii: 13/1/e231844
doi: 10.1136/bcr-2019-231844
pmc: PMC6954780
pii:
doi:
Substances chimiques
Adrenal Cortex Hormones
0
Antigen-Antibody Complex
0
Immunologic Factors
0
Immunosuppressive Agents
0
Rituximab
4F4X42SYQ6
Cyclophosphamide
8N3DW7272P
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© BMJ Publishing Group Limited 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Am J Hematol. 1994 Jul;46(3):189-93
pubmed: 7910717
Clin Nephrol. 2015 Dec;84(6):344-52
pubmed: 26445003
Blood. 2017 Mar 23;129(12):1658-1668
pubmed: 28100459
Blood. 2017 Mar 23;129(12):1646-1657
pubmed: 28087540
Lancet Haematol. 2016 Apr;3(4):e150-2
pubmed: 27063967
Clin Exp Nephrol. 2011 Dec;15(6):921-6
pubmed: 21822592
Nephrol Dial Transplant. 2012 Oct;27 Suppl 3:iii119-25
pubmed: 21602182
Lancet Oncol. 2014 Aug;15(9):966-74
pubmed: 25042199
Nephrol Dial Transplant. 2011 Feb;26(2):599-609
pubmed: 20656751
Blood. 2005 Oct 15;106(8):2627-32
pubmed: 15998837
Hematol Oncol Clin North Am. 2018 Feb;32(1):11-21
pubmed: 29157613
Am J Hematol. 2012 Nov;87(11):997-1002
pubmed: 22791417
Am J Kidney Dis. 2004 Jan;43(1):E3-9
pubmed: 14712466
Intern Med. 2018 Apr 15;57(8):1123-1129
pubmed: 29269660
Oncol Lett. 2018 Feb;15(2):2407-2412
pubmed: 29434951
J Clin Pathol. 1997 Nov;50(11):965-7
pubmed: 9462253
Lancet Haematol. 2016 Apr;3(4):e163-75
pubmed: 27063975
Hematol Oncol Clin North Am. 2018 Feb;32(1):23-36
pubmed: 29157617
Hum Pathol. 2018 Dec;82:258-263
pubmed: 29626596
Blood. 2018 Nov 15;132(20):2115-2124
pubmed: 30181172
Clin Adv Hematol Oncol. 2010 Jul;8(7):486-98
pubmed: 20864917
Br J Haematol. 2018 Jan;180(2):206-216
pubmed: 29143319
N Engl J Med. 2017 Feb 16;376(7):684-692
pubmed: 28199810